Instil Bio, Inc. (TIL) Financials
TIL Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 340.3 million | 106.2 million |
| 2023-06-30 | 408.3 million | 111.8 million |
| 2023-03-31 | 427.2 million | 116.0 million |
| 2022-12-31 | 482.1 million | 118.5 million |
TIL Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -19.6 million | 4.7 million |
| 2023-06-30 | -26.5 million | 4.4 million |
| 2023-03-31 | -43.1 million | 4.5 million |
| 2022-12-31 | -50.0 million | 6.6 million |
TIL Net Income
No data available :(
TIL Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 183.4 million | - | 5.1 million |
| 2023-06-30 | 202.9 million | - | 5.6 million |
| 2023-03-31 | 223.2 million | - | 6.3 million |
| 2022-12-31 | 260.9 million | - | 7.6 million |
TIL Shares Outstanding
TIL Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | 5.2 million | 8.5 million | 11.9 million | - |
| 2023-06-30 | 7.0 million | 8.5 million | 11.5 million | - |
| 2023-03-31 | 8.5 million | 20.7 million | 13.2 million | - |
| 2022-12-31 | 13.0 million | 20.7 million | 12.9 million | - |
TIL Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | - | 953000 |
| 2023-06-30 | - | 835000 |
| 2023-03-31 | - | 2.0 million |
| 2022-12-31 | - | 807000 |
TIL
Price: $10.82
52 week price:
Earnings Per Share: -24.00 USD
P/E Ratio: -0.39
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 566200
Ebitda: -268970Market Capitalization: 72.6 million